Department of Radiology, Ondokuz Mayıs University, Kurupelit, 55210, Samsun, Turkey.
Department of Urology, Ondokuz Mayıs University, Kurupelit, 55210, Samsun, Turkey.
Abdom Radiol (NY). 2019 May;44(5):1841-1849. doi: 10.1007/s00261-019-01897-5.
To investigate whether iodine content can discriminate between benign or malignant renal tumors, malign tumor subtypes, low-grade and high-grade tumors on rapid kv-switching dual-energy CT (rsDECT).
This prospective study enrolled 95 patients with renal tumors who underwent rsDECT for tumor characterization between 2016 and 2018. Attenuation on true and virtual unenhanced images, absolute enhancement and enhancement ratio and iodine content of each lesion on nephrographic phase iodine density images were measured. Histopathological diagnosis was obtained following either surgery or core biopsy.
Eighty-five tumors were renal cell carcinoma (RCC) (56 clear cell, 20 papillary, 9 chromophobe) and 10 were benign (6 angiomyolipoma,4 oncocytoma). 46 tumors were low-grade and 23 high-grade. There was significant difference between iodine content of clear cell and non-clear cell (papillary + chromophobe) RCC (p < 0.001). However, no significant iodine content differences were found between papillary and chromophobe RCC, benign and malignant tumors, low-grade and high-grade tumors. The best cut-off iodine content for differentiating clear cell from non-clear cell RCC was 3.2 mg/ml and clear cell from papillary RCC was 2.9 mg/ml with a high sensitivity and specificity. Also, significant difference was found between attenuation values of true and virtual unenhanced images (p = 0.007). Mean iodine content, absolute enhancement and enhancement ratio were highly correlated.
rsDECT contributes to renal tumor characterization by showing higher iodine content in clear cell RCCs compared with non-clear cell RCCs.
研究碘含量能否在快速 kv 切换双能 CT(rsDECT)上区分良恶性肾肿瘤、恶性肿瘤亚型、低级别和高级别肿瘤。
本前瞻性研究纳入了 2016 年至 2018 年间在 rsDECT 下进行肿瘤特征分析的 95 名肾肿瘤患者。在肾实质期碘密度图像上测量真、虚拟未增强图像上的衰减值、绝对增强值、增强比和每个病变的碘含量。根据手术或核心活检获得组织病理学诊断。
85 个肿瘤为肾细胞癌(RCC)(56 个透明细胞,20 个乳头状,9 个嫌色细胞),10 个为良性(6 个血管平滑肌脂肪瘤,4 个嗜酸细胞瘤)。46 个为低级别,23 个为高级别。透明细胞与非透明细胞(乳头状+嫌色细胞)RCC 的碘含量有显著差异(p<0.001)。然而,在乳头状和嫌色细胞 RCC、良性和恶性肿瘤、低级别和高级别肿瘤之间,未发现碘含量的显著差异。区分透明细胞与非透明细胞 RCC 的最佳碘含量截断值为 3.2mg/ml,区分透明细胞与乳头状 RCC 的最佳碘含量截断值为 2.9mg/ml,具有较高的灵敏度和特异性。此外,真、虚拟未增强图像的衰减值之间存在显著差异(p=0.007)。平均碘含量、绝对增强值和增强比高度相关。
rsDECT 通过显示透明细胞 RCC 的碘含量高于非透明细胞 RCC,有助于肾肿瘤的特征分析。